<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37460408</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>BAFFR expression in circulating T follicular helper (CD4<sup>+</sup>CXCR5<sup>+</sup>PD-1<sup>+</sup>) and T peripheral helper (CD4<sup>+</sup>CXCR5<sup>-</sup>PD-1<sup>+</sup>) cells in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1093</StartPage><EndPage>1104</EndPage><MedlinePgn>1093-1104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231189804</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Circulating T follicular helper (cTfh) and T peripheral helper (Tph) subpopulations are shown to be higher in systemic lupus erythematosus (SLE) patients and have been involved in promoting extrafollicular B cell responses. However, a possible association with the B cell activating factor (BAFF), a cytokine mainly related to B cell responses and disease activity in SLE, has not been investigated. Therefore, this study aimed to evaluate the association of cTfh and Tph subpopulations with the BAFF system expression and clinical activity in SLE patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study included 43 SLE patients and 12 healthy subjects (HS). The identification of cTfh (CD4<sup>+</sup>CXCR5<sup>+</sup>PD-1<sup>+</sup>), Tph (CD4<sup>+</sup>CXCR5<sup>-</sup>PD-1<sup>+</sup>) cells, expression of membrane-bound BAFF (mBAFF), BAFFR, TACI, BCMA, and intracellular IL-21 was performed by flow cytometry. Serum levels of IL-21, CXCL13, and BAFF were analyzed using ELISA. The SLEDAI-2K score was used to evaluate disease activity in SLE patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with HS, SLE patients showed a significantly increased percentage of cTfh and Tph cells, higher in patients with clearly active disease. SLE patients had markedly higher IL-21-producing cTfh and Tph cells than HS. Both subpopulations were positively correlated with the disease activity in SLE patients. Tph cells were negatively correlated with CD19<sup>+</sup>CXCR5<sup>+</sup> B cells and positively correlated with CD19<sup>+</sup>CXCR5<sup>-</sup> B cells. A low expression of mBAFF and their receptors TACI and BCMA was found on cTfh and Tph cells in SLE patients and HS. However, SLE patients with clearly active disease showed decreased expression of BAFFR on cTfh and Tph subpopulations than patients with mildly active/nonactive disease. Serum IL-21, CXCL13, and BAFF levels were higher in SLE patients than in HS. Levels of CXCL13 were correlated with disease activity. Non-significant correlations were observed among T cell subpopulations and IL-21, CXCL13, and BAFF levels.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study emphasizes the importance of cTfh and Tph cells in SLE pathogenesis. Besides the importance of IL-21, our results suggest that BAFFR could play a role in cTfh and Tph subpopulations in the autoimmunity context.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sagrero-Fabela</LastName><ForeName>Nefertari</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Doctorado en Ciencias Biom&#xe9;dicas (DCB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">42571</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ort&#xed;z-Lazareno</LastName><ForeName>Pablo C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Inmunolog&#xed;a, Centro de Investigaci&#xf3;n Biom&#xe9;dica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">130198</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salazar-Camarena</LastName><ForeName>Diana C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Grupo de Inmunolog&#xed;a Molecular, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">42571</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz</LastName><ForeName>Alvaro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Ciencias Biom&#xe9;dicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">42571</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerpa-Cruz</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departamento de Reumatolog&#xed;a, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">103531</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz-Valle</LastName><ForeName>Jos&#xe9; F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Ciencias Biom&#xe9;dicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">42571</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mar&#xed;n-Rosales</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Grupo de Inmunolog&#xed;a Molecular, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">42571</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Hospital General de Occidente, Secretar&#xed;a de Salud Jalisco, Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">37758</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez-G&#xf3;mez</LastName><ForeName>Jhonatan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Doctorado en Ciencias en Biolog&#xed;a Molecular en Medicina (DCBMM), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">42571</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palafox-S&#xe1;nchez</LastName><ForeName>Claudia A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0003-0836-4186</Identifier><AffiliationInfo><Affiliation>Grupo de Inmunolog&#xed;a Molecular, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">42571</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Ciencias Biom&#xe9;dicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, M&#xe9;xico.</Affiliation><Identifier Source="RINGGOLD">42571</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053301">B-Cell Maturation Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C095085">CXCR5 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061026">Programmed Cell Death 1 Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054380">Receptors, CXCR5</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C435926">TNFRSF13C protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053301" MajorTopicYN="N">B-Cell Maturation Antigen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061026" MajorTopicYN="N">Programmed Cell Death 1 Receptor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054380" MajorTopicYN="N">Receptors, CXCR5</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006377" MajorTopicYN="N">T-Lymphocytes, Helper-Inducer</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BAFFR</Keyword><Keyword MajorTopicYN="N">IL-21</Keyword><Keyword MajorTopicYN="N">SLEDAI-2K</Keyword><Keyword MajorTopicYN="N">T peripheral helper (Tph) cells</Keyword><Keyword MajorTopicYN="N">circulating T follicular helper (cTfh) cells</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>18</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>22</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37460408</ArticleId><ArticleId IdType="doi">10.1177/09612033231189804</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>